Kimberly C Banks

11PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 02, 2026
Tumor-Free Circulating Tumor DNA in Node-Negative Rectal Cancers Undergoing Neoadjuvant Chemotherapy, Excision, and Observation in the Phase II NEO Trial (CO.28).

|Jul 29, 2025
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study.

Samantha I Liang, Zoe Quandt, Sara Wienke

|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree, Emma Titmuss, James T Topham

|Aug 25, 2022
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer.

James T Topham, Chris J O'Callaghan, Harriet Feilotter

|Apr 24, 2021
Genomic profile of advanced breast cancer in circulating tumour DNA.

Belinda Kingston, Rosalind J Cutts, Hannah Bye

|Dec 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.

Han Si, Michael Kuziora, Katie J Quinn

Pageof 2

Frequent Collaborators

5 joint publications

Richard B Lanman

3 joint publications

Jonathan M Loree

3 joint publications

Hagen F Kennecke

3 joint publications

Dongsheng Tu